Before joining Hurone AI, Analise was a strategy consultant to the Gates Foundation, global pharmaceutical companies, and leading cancer centers, advising the exact institutions Hurone AI sells into on market entry, partnership structure, and commercial strategy across complex regulatory and payer environments.

She has built and closed institutional partnerships spanning pharma, academia, and integrated health systems on a global scale, with a track record of converting long-cycle relationships into funded programs.

At Hurone AI, she owns the commercial architecture that turns clinical champions into signed contracts.